Ignite Creation Date:
2024-07-17 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06494527
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-07-02
Brief Title:
A Phase 1 Study to Evaluate the SafetyTolerability PKPD of RG002C0106 Injection in Healthy Adults
Sponsor:
Rigerna Therapeutics Beijing Rigerna Therapeutics Suzhou Rigerna OA Therapeutics Pty Ltd
Organization:
Rigerna Therapeutics Beijing Rigerna Therapeutics Suzhou Rigerna OA Therapeutics Pty Ltd
Organization Data
Organization:
Rigerna Therapeutics Beijing Rigerna Therapeutics Suzhou Rigerna OA Therapeutics Pty Ltd
Class:
INDUSTRY
Study ID:
RG002C0106-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rigerna Therapeutics Beijing Rigerna Therapeutics Suzhou Rigerna OA Therapeutics Pty Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None